VACCINE STRAIN OF INFLUENZA VIRUS A/17/BRISBANE/2018/8175 (H1N1) PDM09 FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN

摘要

FIELD: biotechnology.;SUBSTANCE: invention relates to the field of biotechnology. Invention is a strain of virus A/17/Brisbane (2018/8175 (H1N1) pdm09 – reassortant, produced by crossing epidemic virus A/Brisbane/02/2018 (H1N1) pdm09 with cold-adapted temperature-sensitive virus A/Leningrad/134/17/57 (H2N2) – an attenuation donor harmless for humans.;EFFECT: invention can be used for prevention of influenza prevalence among adults and children with the help of live influenza intranasal vaccine of strain of influenza A/17/Brisbane/2018/8175 (H1N1) pdm09 virus.;1 cl, 5 tbl